n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
After 3 Years of Clinical Studies on Brain Imaging and Happiness Research, Matter Launches Public Beta App
NEW YORK, Feb. 27, 2024 /PRNewswire/ — Matter Neuroscience, the company that seeks to better perceive happiness and well-being by providing others with personalized data about their brain chemistry, is now coming out of stealth mode. Matter announced that it has won $26 million in investment, an initial investment through Polaris Partners and a more recent circular co-led through ARCH Venture Partners, Polaris Partners, and Exor Ventures, and joined through the Collaborative Fund and others. With this support, Matter will continue its efforts to locate pioneering responses that combat the epidemic of unhappiness by transforming our perception and control of intellectual well-being.
Identifying a Biomarker of Happiness Currently in its third year of clinical studies with leading laboratories in the fields of brain imaging and happiness research, Matter is on a project to identify a biomarker of happiness. Such a discovery would improve our understanding of the biological activity that underlies happiness. feelings and lead to further breakthroughs in depression, anxiety, addiction, and aggression disorders. These studies are led by renowned researchers, added Professor Rainer Goebel of the Center for Brain Imaging at Maastricht University and a member of the Scientific and Infrastructure Council of the Human Brain Project. , Meik Wiking and the team from the Happiness Research Institute, as well as professors from the Icahn School of Medicine.
The effects of the most recent high-field functional magnetic resonance imaging studies conducted by Prof. Goebel and his team, who examine the neuroscientific basis of the positive feelings and well-being app Matter, will be presented at the 2024 Annual Meeting of the Organization for Mapping the Human Being. Brain. Se full information and research from the study is expected to be published later this year.
“Based on the initial effects of our study, we see strong evidence of a universal map of distinct positive feelings in the human brain,” Professor Goebel said. “In addition to guiding healthy Americans toward greater well-being, this may simply pave the way for education in emotion regulation for the remedy of depression. “
Together with its collaborating partners, Matter Neuroscience will publish 3 more studies in 2024.
Improving Health and Happiness with Matter Taking into account the early positive effects on subjective well-being and brain markers in clinical studies, Matter has launched a first edition of its public beta app for interested and physically fit users and plans to further expand the generation in which it has worked effectively. used. clinical studies through public use of the app. The app is designed to provide Americans with a tool to record and reflect on their positive experiences, to better perceive neurotransmitter activity, and to make adjustments in their daily lives to improve their fitness. and happiness. Matter also gives users access to educational fabrics and a lecture series on the neuroscience of happiness.
For more information and for a beta user of the Matter app, visit www. matter. xyz.
MatterMatter’s neuroscience team is led by Axel Bouchon, a veteran biotech and pharmaceutical executive, who in the past led the venture capital arms of Moderna and Bayer and is a partner at ARCH Venture. Driven by a preference to avoid unhappiness for himself and for others. While millions of people are at risk of developing intellectual illness, Bouchon spent several years working to understand the molecular basis of happiness in our brains.
Bouchon’s ideas, published in his book “Happiness Capitalism,” gave rise to Matter Neuroscience’s vision: to find a set of rules that allow other people to understand and harness their natural molecular compass to achieve happiness. Matter Neuroscience co-founded in 2019 with Ben Goldhirsh of GOOD Worldwide and the Goldhirsh Foundation, and Chris Shiflett of the Faculty and Brooklyn Beta.
“The world’s wealthiest regions are grappling with record levels of depression, addiction and anxiety,” said Axel Bouchon, CEO and co-founder of Matter Neuroscience. “Our customer culture systematically blocks brain progression and erodes intellectual health. Matter offers a scientifically biological, biological, indicator of human progress and sustainable happiness. “
Matter Neuroscience’s independent Scientific and Clinical Advisory Board includes Prof. Daniela Schiller (Departments of Neuroscience and Psychiatry, Icahn School of Medicine at Mount Sinai), Prof. Zahi Fayad (Lucy G. Moses Prof. of Medical Imaging and Bioengineering at the Icahn School of Medicine at Mount Sinai, Institute of Biomedical Imaging and Engineering) and Prof. Konstantin Nikolaou (Professor and Chairman of the Department of Diagnostic and Interventional Radiology, University Hospitals Tübingen, Germany), as well as Prof. Goebel (Maastricht University) and Meik Wiking (Happiness Research Institute).
Paul Berns of ARCH Venture Partners and Amir Nashat of Polaris Partners on Matter’s board of directors. Berns is a veteran biopharmacist and entrepreneur with more than 30 years of good fortune in the field of neurology. Nashat is an active investor and entrepreneur in the healthcare sector. and has been included in the Forbes Midas list of the “Top Hundred Venture Capitalists. “
About MatterMatter Neuroscience, founded in 2019 by Axel Bouchon and Ben Goldhirsh. Chris Shiflett joined the company in 2021 as a co-founder. Matter’s project is to use neuroscience to help other people live longer, healthier, and happier lives so that, separately, we can succeed. Our whole perspective and together we can solve the world’s most pressing problems. Matter is led by CEO Axel Bouchon (Moderna, Bayer, ARCH Venture Partners). The COO of Matter is Bridget Best (Kickstarter, Sweeten). Ben Goldhirsh (GOOD Worldwide and Goldhirsh Foundation) is the president of Matter.
Visit www. matter. xyz to learn more about Matter and sign up for the beta. Follow Matter on Instagram and Tiktok for data and inspiration to live a happier life.
Check out the content to download multimedia: https://www. prnewswire. com/news-releases/matter-neuroscience-secures-26m-in-funding-to-cure-unhappiness-302072626. html
SOURCE Subject Neuroscience